Debates & Insight Sponsored Digital health: how can technology be used to engage hard-to... Helping someone live with a condition as complex as MS can be fraught with challenges.
Debates & Insight Sponsored Disruption and maturity: the future directions for biologics Is the UK’s NHS saving enough from the new wave of biosimilars?
Debates & Insight Sponsored Approval and access: overcoming the final hurdle of drug dev... 2017 is likely to be a year of significant change for pharma brands in Europe. With affordability on the agenda for almost every country in the region, a move toward greater collaboration in health
Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.